Activation of H-ras(61L)-specific signaling pathways does not require posttranslational processing of H-ras

Experimental Cell Research

Volumn 257, Issue 1, 2000, Pages 89-100

  Hart, Kristen C ^a   Robertson, Scott C ^a   Donoghue, Daniel J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

H ras; MAPK cascade; Posttranslational modifications; Protein localization; Signal transduction

Indexed keywords

ACTIN; LIPID; PHOSPHATIDYLINOSITOL 3 KINASE; RAC PROTEIN; RAS PROTEIN; RHO FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; GENE ACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NERVE FIBER GROWTH; NONHUMAN; ONCOGENE H RAS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL DIFFERENTIATION; CELL STRAIN; CYTOLOGY; METABOLISM;

ANIMALIA;

ANIMALS; CELL DIFFERENTIATION; MAP KINASE SIGNALING SYSTEM; PC12 CELLS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RAS PROTEINS; RATS; SIGNAL TRANSDUCTION;

EID: 0034713008     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4874     Document Type: Article

References (71)

1. Hall A. Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annu. Rev. Cell Biol. 10:1994;31-54.
2. Symons M. Rho family GTPases: The cytoskeleton and beyond. Trends Biochem. Sci. 21:1996;178-181.
3. Tapon N., Hall A. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr. Opin. Cell Biol. 9:1997;86-92.
4. Zhang F. L., Casey P. J. Protein prenylation: Molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65:1996;241-269.
5. Abrams S. I., Hand P. H., Tsang K. Y., Schlom J. Mutant ras epitopes as targets for cancer vaccines. Semin. Oncol. 23:1996;118-134.
6. Leonard D. M. Ras farnesyltransferase: A new therapeutic target. J. Med. Chem. 40:1997;2971-2990.
7. Gibbs J. B. Ras C-terminal processing enzymes - New drug targets. Cell. 65:1991;1-4.
8. Khosravi-Far R., Cox A. D., Kato K., Der C. J. Protein prenylation: Key to ras function and cancer intervention. Cell Growth Differ. 3:1992;461-469.
9. Sebti S. M., Hamilton A. D. Inhibition of Ras prenylation: A novel approach to cancer chemotherapy. Pharmacol. Ther. 74:1997;103-114.
10. Waddick K. G., Uckun F. M. Innovative treatment programs against cancer. I: Ras oncoprotein as a molecular target. Biochem. Pharmacol. 56:1998;1411-1426.
11. Adamson P., Marshall C. J., Hall A., Tilbrook P. A. Post-translational modifications of P21(rho) proteins. J. Biol. Chem. 267:1992;20033-20038.
12. Adamson P., Paterson H. F., Hall A. Intracellular localization of the P21(rho) proteins. J. Cell Biol. 119:1992;617-627.
13. Lebowitz P. F., Du W., Prendergast G. C. Prenylation of RhoB is required for its cell transforming function but not its ability to activate serum response element-dependent transcription. J. Biol. Chem. 272:1997;16093-16095.
14. Kikuchi A., Williams L. T. The post-translational modification of ras p21 is important for Raf-1 activation. J. Biol. Chem. 269:1994;20054-20059.
15. Okada T., Masuda T., Shinkai M., Kariya K., Kataoka T. Post-translational modification of H-Ras is required for activation of, but not for association with, B-Raf. J. Biol. Chem. 271:1996;4671-4678.
16. Rubio I., Wittig U., Meyer C., Heinze R., Kadereit D., Waldmann H., Downward J., Wetzker R. Farnesylation of Ras is important for the interaction with phosphoinositide 3-kinase gamma. Eur. J. Biochem. 266:1999;70-82.
17. Itoh T., Kaibuchi K., Masuda T., Yamamoto T., Matsuura Y., Maeda A., Shimizu K., Takai Y. The post-translational processing of ras p21 is critical for its stimulation of mitogen-activated protein kinase. J. Biol. Chem. 268:1993;3025-3028.
18. Marshall C. J. Protein prenylation: A mediator of protein-protein interactions. Science. 259:1993;1865-1866.
19. Kuroda Y., Suzuki N., Kataoka T. The effect of posttranslational modifications on the interaction of Ras2 with adenylyl cyclase. Science. 259:1993;683-686.
20. Hancock J. F., Magee A. I., Childs J. E., Marshall C. J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell. 57:1989;1167-1177.
21. Cadwallader K. A., Paterson H., Macdonald S. G., Hancock J. F. N-terminally myristoylated Ras proteins require palmitoylation or a polybasic domain for plasma membrane localization. Mol. Cell. Biol. 14:1994;4722-4730.
22. Lacal P. M., Pennington C. Y., Lacal J. C. Transforming activity of ras proteins translocated to the plasma membrane by a myristoylation sequence from the src gene product. Oncogene. 2:1988;533-537.
23. Buss J. E., Solski P. A., Schaeffer J. P., MacDonald M. J., Der C. J. Activation of the cellular proto-oncogene product p21ras by addition of a myristylation signal. Science. 243:1989;1600-1603.
24. Hart K. C., Donoghue D. J. Derivatives of activated H-ras lacking C-terminal lipid modifications retain transforming ability if targeted to the correct subcellular location. Oncogene. 14:1997;945-953.
25. Prendergast G. C., Khosravi-Far R., Solski P. A., Kurzawa H., Lebowitz P. F., Der C. J. Critical role of Rho in cell transformation by oncogenic Ras. Oncogene. 10:1995;2289-2296.
26. Khosravi-Far R., Solski P. A., Clark G. J., Kinch M. S., Der C. J. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol. Cell. Biol. 15:1995;6443-6453.
27. Qiu R. G., Chen J., Kirn D., McCormick F., Symons M. An essential role for Rac in Ras transformation. Nature. 374:1995;457-459.
28. Qiu R. G., Chen J., McCormick F., Symons M. A role for Rho in Ras transformation. Proc. Natl. Acad. Sci. USA. 92:1995;11781-11785.
29. Rodriguez-Viciana P., Warne P. H., Khwaja A., Marte B. M., Pappin D., Das P., Waterfield M. D., Ridley A., Downward J. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell. 89:1997;457-467.
30. Willumsen B. M., Christensen A., Hubbert N. L., Papageorge A. G., Lowy D. R. The p21 ras C-terminus is required for transformation and membrane association. Nature. 310:1984;583-586.
31. ras is two-step and involves carboxyl-methlation and carboxy-terminal proteolysis. EMBO J. 8:1989;1093-1098.
32. Alessi D. R., Cohen P., Ashworth A., Cowley S., Leevers S. J., Marshall C. J. Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf. Meth. Enzymol. 255:1995;279-290.
33. Swift A. M., Machamer C. E. A Golgi retention signal in a membrane-spanning domain of coronavirus E1 protein. J. Cell Biol. 115:1991;19-30.
34. Hart K. C., Xu Y.-F., Meyer A. N., Lee B. A., Donoghue D. J. The v-sis oncoprotein loses transforming activity when targeted to the early Golgi. J. Cell Biol. 127:1994;1843-1857.
35. Brandt-Rauf P. W., Carty R. P., Chen J. M., Lee G., Rackovsky S., Pincus M. R. The structure of the carboxyl terminus of the p21 protein: Structural relationship to the nucleotide-binding/transforming regions of the protein. J. Protein Chem. 9:1990;137-142.
36. Stokoe D., Macdonald S. G., Cadwallader K., Symons M., Hancock J. F. Activation of Raf as a result of recruitment to the plasma membrane. Science. 264:1994;1463-1467.
37. Leevers S. J., Paterson H. F., Marshall C. J. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature. 369:1994;411-414.
38. Traverse S., Cohen P., Paterson H., Marshall C., Rapp U., Grand R. J. Specific association of activated MAP kinase kinase kinase (Raf) with the plasma membranes of ras-transformed retinal cells. Oncogene. 8:1993;3175-3181.
39. Fabian J. R., Daar I. O., Morrison D. K. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol. Cell. Biol. 13:1993;7170-7179.
40. Marais R., Light Y., Paterson H. F., Marshall C. J. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14:1995;3136-3145.
41. Diaz B., Barnard D., Filson A., MacDonald S., King A., Marshall M. Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling. Mol. Cell. Biol. 17:1997;4509-4516.
42. Roy S., McPherson R. A., Apolloni A., Yan J., Lane A., Clyde-Smith J., Hancock J. F. 14-3-3 facilitates Ras-dependent Raf-1 activation in vitro and in vivo. Mol. Cell. Biol. 18:1998;3947-3955.
43. Tzivion G., Luo Z., Avruch J. A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature. 394:1998;88-92.
44. Daub M., Jockel J., Quack T., Weber C. K., Schmitz F., Rapp U. R., Wittinghofer A., Block C. The RafC1 cysteine-rich domain contains multiple distinct regulatory epitopes which control Ras-dependent Raf activation. Mol. Cell. Biol. 18:1998;6698-6710.
45. Ghosh S., Strum J. C., Bell R. M. Lipid biochemistry: Functions of glycerolipids and sphingolipids in cellular signaling. FASEB J. 11:1997;45-50.
46. Ghosh S., Strum J. C., Sciorra V. A., Daniel L., Bell R. M. Raf-1 kinase possesses distinct binding domains for phosphatidylserine and phosphatidic acid: Phosphatidic acid regulates the translocation of Raf-1 in 12-O-tetradecanoylphorbol-13-acetate-stimulated Madin-Darby canine kidney cells. J. Biol. Chem. 271:1996;8472-8480.
47. Kyriakis J. M., App H., Zhang X., Banerjee P., Brautigan D. L., Rapp U. R., Avruch J. Raf-1 activates MAP kinase-kinase. Nature. 358:1992;417-421.
48. Ray L. B., Sturgill T. W. Insulin-stimulated microtubule-associated protein kinase is phosphorylated on tyrosine and threonine in vitro. Proc. Natl. Acad. Sci. USA. 85:1988;3753-3757.
49. Ahn N. G., Seger R., Krebs E. G. The mitogen-activated protein kinase activator. Curr. Opin. Cell Biol. 4:1992;992-999.
50. Marshall C. J. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev. 4:1994;82-89.
51. Cobb M. H., Goldsmith E. J. How MAP kinases are regulated. J. Biol. Chem. 270:1995;14843-14846.
52. Lenormand P., Sardet C., Pages G., L'Allemain G., Brunet A., Pouyssegur J. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell Biol. 122:1993;1079-1088.
53. Janknecht R., Hunter T. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J. 16:1997;1620-1627.
54. Deng T., Karin M. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature. 371:1994;171-175.
55. Franke T. F., Yang S. I., Chan T. O., Datta K., Kazlauskas A., Morrison D. K., Kaplan D. R., Tsichlis P. N. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:1995;727-736.
56. Duronio V., Scheid M. P., Ettinger S. Downstream signalling events regulated by phosphatidylinositol 3-kinase activity. Cell. Signalling. 10:1998;233-239.
57. Bar-Sagi D., Feramisco J. R. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell. 42:1985;841-848.
58. Qui M. S., Green S. H. PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron. 9:1992;705-717.
59. Marshall C. J. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
60. Booden M. A., Baker T. L., Solski P. A., Der C. J., Punke S. G., Buss J. E. A non-farnesylated Ha-Ras protein can be palmitoylated and trigger potent differentiation and transformation. J. Biol. Chem. 274:1999;1423-1431.
61. Luo Z., Diaz B., Marshall M. S., Avruch J. An intact Raf zinc finger is required for optimal binding to processed Ras and for ras-dependent Raf activation in situ. Mol. Cell. Biol. 17:1997;46-53.
62. Roy S., Lane A., Yan J., McPherson R., Hancock J. F. Activity of plasma membrane-recruited Raf-1 is regulated by Ras via the Raf zinc finger. J. Biol. Chem. 272:1997;20139-20145.
63. Rodriguez-Concepcion M., Yalovsky S., Zik M., Fromm H., Gruisse W. The prenylation status of a novel plant calmodulin directs plasma membrane or nuclear localization of the protein. EMBO J. 18:1999;1996-2007.
64. Melkonian K. A., Ostermeyer A. G., Chen J. Z., Roth M. G., Brown D. A. Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts: Many raft proteins are acylated, while few are prenylated. J. Biol. Chem. 274:1999;3910-3917.
65. Choy E., Chiu V. K., Silletti J., Feoktistov M., Morimoto T., Michaelson D., Ivanov I. E., Philips M. R. Endomembrane trafficking of ras: The CAAX motif targets proteins to the ER and Golgi. Cell. 98:1999;69-80.
66. Voice J. K., Klemke R. L., Le A., Jackson J. H. Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J. Biol. Chem. 274:1999;17164-17170.
67. Milligan G., Parenti M., Magee A. The dynamic role of palmitoylation in signal transduction. Trends. Biochem. Sci. 20:1995;181-187.
68. De Vos A. M., Tong L., Milburn M. V., Matias P. M., Jancarik J., Noguchi S., Nishimura S., Miura K., Ohtsuka E., Kim S.-H. Three-dimensional structure of an oncogene protein: Catalytic domain of human c-H-ras p21. Science. 239:1988;888-893.
69. Pai E. F., Kabsch W., Krengel U., Holmes K. C., John J., Wittinghofer A. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation. Nature. 341:1989;209-214.
70. Seabra M. C. Membrane association and targeting of prenylated Ras-like GTPases. Cell. Signalling. 10:1998;167-172.
71. Colley K. J. Golgi localization of glycosyltransferases: More questions than answers. Glycobiol. 7:1997;1-13.